Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Caliway Biopharmaceuticals, headquartered in Taiwan, is an innovative pharmaceutical company specializing in the development of novel therapeutics. The company focuses on the research and clinical testing of medical solutions aimed at treating various dermatological and oncological diseases.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Caliway Biopharmaceuticals is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Caliway Biopharmaceuticals last reported quarterly earnings on 4/10/2026 (Q1 2026). Earnings per share (EPS) came in at -0.22 TWD.
Caliway Biopharmaceuticals has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.